TipRanks
Go Ultimate55% OFF

Dr Reddy's Laboratories (RDY) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

RDY Analyst Ratings

Moderate Buy
3Ratings
2Buy1Hold0Sell
Based on 3 analysts giving stock ratings to Dr Reddy's Laboratories in the past 3 months

RDY Stock 12 Month Forecast

$14.34▲(1.23% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Dr Reddy's Laboratories in the last 3 months. The average price target is $14.34 with a high forecast of $14.80 and a low forecast of $13.89. The average price target represents a 1.23% change from the last price of $14.17.
Highest Price Target$14.80Average Price Target$14.34Lowest Price Target$13.89

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for RDY
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
Bank of America Securities―buy―Reiterated10/26/26
Jefferies$13.89hold-1.99%DownsideUpgraded10/25/26
Exane BNP Paribas Analyst forecast on RDYTausif ShaikhNot RankedExane BNP Paribas$14.80buy4.45%UpsideUpgraded10/12/26
Citi Analyst forecast on RDYUnknown AnalystNot RankedCiti―sell―Reiterated04/23/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr Reddy's Laboratories

3 Months
Neha Manpuria
Neha ManpuriaBank of America Securities
Success Rate2/6 ratings generated profit
33%
Average Return
+1.20%

Copying Neha Manpuria's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +1.20% per trade.

1 Year
Neha Manpuria
Neha ManpuriaBank of America Securities
Success Rate2/6 ratings generated profit
33%
Average Return
+0.33%

Copying Neha Manpuria's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +0.33% per trade.

2 Years
Neha Manpuria
Neha ManpuriaBank of America Securities
Success Rate2/6 ratings generated profit
33%
Average Return
-3.03%

Copying Neha Manpuria's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -3.03% per trade.

RDY Analyst Recommendation Trends

01234Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for RDY
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy11103
Hold00001
Sell10000
Strong Sell00000
total21104

In the current month, RDY has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. RDY average Analyst price target in the past 3 months is 14.34.

RDY Financial Forecast

$-1$-0.5$0$0.5$1Q4 2026Q2 2027Q3 2027
High$0.13
Consensus$0.13
Low$0.12

RDY Earnings Forecast

Next quarter’s earnings estimate for RDY is $0.13 with a range of $0.12 to $0.13. The previous quarter’s EPS was $0.12. RDY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RDY has Performed in-line its overall industry.

$821M$860.9M$900.8M$940.6M$980.5MQ4 2026Q2 2027Q3 2027
High$981M
Consensus$953M
Low$937M

RDY Sales Forecast

Next quarter’s sales forecast for RDY is $952.73M with a range of $937.49M to $980.50M. The previous quarter’s sales results were $907.22M. RDY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RDY has Performed in-line its overall industry.

RDY Stock Forecast FAQ

What is RDY’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr Reddy's Laboratories’s 12-month average price target is $14.34.
What is RDY’s upside potential, based on the analysts’ average price target?
Dr Reddy's Laboratories has 1.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RDY a Buy, Sell or Hold?
Dr Reddy's Laboratories has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Dr Reddy's Laboratories’s price target?
The average price target for Dr Reddy's Laboratories is $14.34. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $14.80, the lowest forecast is $13.89. The average price target represents a 1.23% increase from the current price of $14.17.
What do analysts say about Dr Reddy's Laboratories?
Dr Reddy's Laboratories’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of RDY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.